SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-213049
Filing Date
2019-08-05
Accepted
2019-08-05 16:59:26
Documents
4
Effectiveness Date
2019-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 d764098ds8.htm S-8 47474
2 EX-5.1 d764098dex51.htm EX-5.1 5765
3 EX-23.1 d764098dex231.htm EX-23.1 2262
4 GRAPHIC g764098g55h17.jpg GRAPHIC 3973
  Complete submission text file 0001193125-19-213049.txt   62142
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233027 | Film No.: 19999392
SIC: 2834 Pharmaceutical Preparations